Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
UPDATE: Cantor Fitzgerald Assumes Aziyo Biologics Inc. (AZYO) at Overweight, PT Lowered to $12
-
MSP Recovery Reaffirms Revenue Guidance Originally Set Forth in Prior Financial Models and Announces Substantial Business Expansion Through Development of Additional Revenue Streams, Monetization of A
-
MSP Recovery Reaffirms Revenue Guidance Originally Set Forth in Prior Financial Models and Announces Substantial Business Expansion Through Development of Additional Revenue Streams, Monetization of A
-
ECARX to Go Public in $3.82 Billion Merger with COVA Acquisition Corp. (COVA)
-
ECARX to Go Public in $3.82 Billion Merger with COVA Acquisition Corp., Accelerating Development of Next-Generation Automotive Intelligence
-
ShotSpotter Sets June 2022 Financial Conference Schedule
-
Chinook Therapeutics (KDNY) Prices $105M Public Offering at $14/sh
-
Chinook Therapeutics Announces Pricing of a $105 Million Public Offering
-
Chinook Therapeutics (KDNY) Announces Proposed Stock Offering, Size not Disclosed
-
Chinook Therapeutics Announces Proposed Public Offering
-
"VTAMA Has Blockbuster Potential" - Cantor Fitzgerald Bullish on Roivant Sciences (ROIV) Following Dermavant’s Drug Approval
-
Enovix to Participate in Upcoming Investor Conferences
-
Enovix to Participate in Upcoming Investor Conferences
-
Cantor Fitzgerald Starts Similarweb Ltd (SMWB) at Neutral
-
Cantor Fitzgerald Assumes Rapt Therapeutics (RAPT) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Lyra Therapeutics (LYRA) at Overweight
-
Form 13F-NT/A Cantor Fitzgerald Europe For: Mar 31
-
Form 13F-NT/A CANTOR FITZGERALD & CO. For: Mar 31
-
Form 13F-NT/A CANTOR FITZGERALD SECURI For: Mar 31
-
Form 13F-HR/A CANTOR FITZGERALD, L. For: Mar 31
-
"Approval of Tyvaso DPI Marks Significant Inflection Point", Shares Present "Upside From Current Levels" - Cantor Fitzgerald Bullish on MannKind (MNKD) with $6.50 Price Target
-
Sanara MedTech (SMTI) PT Lowered to $40 at Cantor Fitzgerald, Overweight Rating Maintained
-
Near to go Public on Nasdaq via Merger with KludeIn I Acquisition Corp. (INKA)
-
Near, a Global Leader in Privacy-Led Data Intelligence, to go Public on Nasdaq via a Merger with KludeIn I Acquisition Corp.
-
/C O R R E C T I O N -- Near North America, Inc./
-
Data intelligence firm Near to go public via $1 billion SPAC deal
-
Investors jolted as U.S. retailers show inflation hitting consumers
-
Investors jolted as U.S. retailers show inflation hitting consumers
-
Investors jolted as U.S. retailers show inflation hitting consumers
-
Form 4 BGC Partners, Inc. For: May 17 Filed by: CANTOR FITZGERALD, L. P.
-
Cantor Fitzgerald Reiterates Overweight Rating, $53 Price Target on Insmed (INSM)
-
Form 4 NEWMARK GROUP, INC. For: May 17 Filed by: CANTOR FITZGERALD, L. P.
-
Allakos Inc. (ALLK) PT Lowered to $10 at Cantor Fitzgerald, But BUY Rating Maintained, "Still Believe that the Market Opportunity for lirentelimab is Underappreciated"
-
Cantor Fitzgerald Reiterates Overweight Rating, $7 Price Target on VolitionRX (VNRX), Has a "More Favorable View of the Company"
-
Cantor Fitzgerald Reiterates Overweight Rating, $19 Price Target on Exagen (XGN) on Alivio Health Agreement
-
Form SC 13D/A Satellogic Inc. Filed by: CANTOR FITZGERALD, L. P.
-
Form 424B3 Cantor Fitzgerald Income
-
Enigma Securities Appoints Barry Finkelstein as Global Head of Investment Banking
-
Appreciate to Go Public Via Merger with PropTech Investment Corporation II (PTICU)
-
PropTech Investment Corporation II to Combine with Appreciate, Bringing Single Family Rental Marketplace & Management Platform, Renters Warehouse, to the Public Markets
-
PropTech Investment Corporation II to Combine with Appreciate, Bringing Single Family Rental Marketplace & Management Platform, Renters Warehouse, to the Public Markets
-
Cantor Fitzgerald Reiterates Neutral Rating on TherapeuticsMD (TXMD)
-
UPDATE: Aytu Biosciences (AYTU) PT Lowered to $5 at Cantor Fitzgerald, "Overweight" Rating Reiterated, Analyst Expects "Upwards Earnings Revisions Should Drive Shares Higher"
-
Spero Therapeutics (SPRO) PT Slashed to $5 at Cantor Fitzgerald, Analyst Maintains "Overweight" Rating
-
Form 13F-NT CANTOR FITZGERALD & CO. For: Mar 31
-
Form 13F-HR CANTOR FITZGERALD, L. For: Mar 31
-
Form 13F-NT CANTOR FITZGERALD SECURI For: Mar 31
-
Form 13F-NT Cantor Fitzgerald Europe For: Mar 31
-
Form 10-Q Cantor Fitzgerald Income For: Mar 31
-
Form SC 13G Cartesian Growth Corp Filed by: CANTOR FITZGERALD SECURITIES

